-
DoJ Takes Action On Insys For 'Unfair, Deceptive Marketing Practices' Of Fentanyl Drug
Thursday, January 19, 2017 - 12:20pm | 475Read More...Insys Therapeutics Inc (NASDAQ: INSY) is a commercial-stage specialty pharmaceutical company whose product Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients On Thursday, shares of Insys fell more than 3 percent after the Department of Justice...
-
Market Wrap For March 4: Bulls Take Over As Ukraine Fears Dissipate
Tuesday, March 4, 2014 - 5:37pm | 2664Read More...U.S. stocks recovered and posted strong gains as concerns over a military conflict involving Russia and Ukraine dissipated overnight. The Dow posted a triple digit point gain, recording its best day of the year. The S&P 500 surged to new all time highs of 1,876.23 while the Nasdaq hit new...



